(Q30426630)

21 June 2017

1 reference

title

Recent progress and challenges in the discovery of new neuraminidase inhibitors (English)

1 reference

21 June 2017

Supakarn Chamni

1

1 reference

21 June 2017

Wanchai De-Eknamkul

series ordinal

2

1 reference

21 June 2017

language of work or name

English

0 references

publication date

1 February 2013

1 reference

Expert Opinion on Therapeutic Patents

21 June 2017

published in

1 reference

21 June 2017

volume

23

1 reference

21 June 2017

issue

4

1 reference

21 June 2017

page(s)

409-423

1 reference

Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007-08 season

21 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.765861

Emergence of a novel swine-origin influenza A (H1N1) virus in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.765861

WHO Rapid Advice Guidelines for pharmacological management of sporadic human infection with avian influenza A (H5N1) virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.765861

Oseltamivir resistance mutation N294S in human influenza A(H5N1) virus in Egypt

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.765861

Oseltamivir resistance during treatment of influenza A (H5N1) infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.765861

Avian flu: isolation of drug-resistant H5N1 virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.765861

Emergence and pandemic potential of swine-origin H1N1 influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.765861

Structures of influenza A proteins and insights into antiviral drug targets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.765861

The war against influenza: discovery and development of sialidase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.765861

Neuraminidase inhibitors for influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.765861

Antivirals for influenza: historical perspectives and lessons learned

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.765861

Influenza neuraminidase: a druggable target for natural products

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.765861

Systematic structure-based design and stereoselective synthesis of novel multisubstituted cyclopentane derivatives with potent antiinfluenza activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.765861

Antiviral potential and molecular insight into neuraminidase inhibiting diarylheptanoids from Alpinia katsumadai.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.765861

Susceptibilities of antiviral-resistant influenza viruses to novel neuraminidase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.765861

Synthesis and in vitro study of novel neuraminidase inhibitors against avian influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.765861

Functional balance between haemagglutinin and neuraminidase in influenza virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.765861

Influenza A pandemics of the 20th century with special reference to 1918: virology, pathology and epidemiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.765861

21 January 2018

Influenza neuraminidase

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.765861

Systematic review of influenza resistance to the neuraminidase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.765861

The medicinal potential of influenza virus surface proteins: hemagglutinin and neuraminidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.765861

Anti-influenza drugs: the development of sialidase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.765861

Different synthetic strategies of oseltamivir phosphate: a potent influenza neuraminidase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.765861

Recent progress in rational drug design of neuraminidase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.765861

Strategies of development of antiviral agents directed against influenza virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.765861

Neuraminidase inhibitor resistance in influenza viruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.765861

Structure and functions of influenza virus neuraminidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.765861

Another look at the molecular mechanism of the resistance of H5N1 influenza A virus neuraminidase (NA) to oseltamivir (OTV).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.765861

Comparison of efficacies of RWJ-270201, zanamivir, and oseltamivir against H5N1, H9N2, and other avian influenza viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.765861

Advances in the structure-based design of the influenza A neuraminidase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.765861

The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.765861

Characterizing loop dynamics and ligand recognition in human- and avian-type influenza neuraminidases via generalized born molecular dynamics and end-point free energy calculations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.765861

Mechanism of 150-cavity formation in influenza neuraminidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.765861

In-Silico screening of Pleconaril and its novel substituted derivatives with Neuraminidase of H1N1 Influenza strain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.765861

Crystal structure of a new benzoic acid inhibitor of influenza neuraminidase bound with a new tilt induced by overpacking subsite C6

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.765861

On the structure-based design of novel inhibitors of H5N1 influenza A virus neuraminidase (NA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.765861

Design of oseltamivir analogs inhibiting neuraminidase of avian influenza virus H5N1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.765861

Zanamivir susceptibility monitoring and characterization of influenza virus clinical isolates obtained during phase II clinical efficacy studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.765861

Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl-alpha-D-N-acetylneuraminate) substrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.765861

Neuraminidase activity assays for monitoring MDCK cell culture derived influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.765861

The chemiluminescent neuraminidase inhibition assay: a functional method for detection of influenza virus resistance to the neuraminidase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.765861

Development of a sensitive chemiluminescent neuraminidase assay for the determination of influenza virus susceptibility to zanamivir

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.765861

Assessment of pandemic and seasonal influenza A (H1N1) virus susceptibility to neuraminidase inhibitors in three enzyme activity inhibition assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.765861

Evaluation of neuraminidase enzyme assays using different substrates to measure susceptibility of influenza virus clinical isolates to neuraminidase inhibitors: report of the neuraminidase inhibitor susceptibility network.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.765861

Structure-activity relationship of flavonoids as influenza virus neuraminidase inhibitors and their in vitro anti-viral activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.765861

Structural relationship and binding mechanisms of five flavonoids with bovine serum albumin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.765861

Interaction of alpinetin with bovine serum albumin: Probing of the mechanism and binding site by spectroscopic methods.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.765861

Biological relevance of the interaction between procyanidins and trypsin: a multitechnique approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.765861

The evolution of influenza resistance and treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.765861

Rational design of potent sialidase-based inhibitors of influenza virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.765861

Inhibition of neuraminidase activity by derivatives of 2-deoxy-2,3-dehydro-N-acetylneuraminic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.765861

Rapid selection of oseltamivir- and peramivir-resistant pandemic H1N1 virus during therapy in 2 immunocompromised hosts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.765861

Intravenous zanamivir for oseltamivir-resistant 2009 H1N1 influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.765861

Dimeric zanamivir conjugates with various linking groups are potent, long-lasting inhibitors of influenza neuraminidase including H5N1 avian influenza.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.765861

Highly potent and long-acting trimeric and tetrameric inhibitors of influenza virus neuraminidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.765861

Developing new antiviral agents for influenza treatment: what does the future hold?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.765861

CS-8958, a prodrug of the new neuraminidase inhibitor R-125489, shows long-acting anti-influenza virus activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.765861

Synthesis and anti-influenza evaluation of polyvalent sialidase inhibitors bearing 4-guanidino-Neu5Ac2en derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.765861

Building a successful structural motif into sialylmimetics-cyclohexenephosphonate monoesters as pseudo-sialosides with promising inhibitory properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.765861

Noncovalent binding between guanidinium and anionic groups: focus on biological- and synthetic-based arginine/guanidinium interactions with phosph[on]ate and sulf[on]ate residues

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.765861

A practical synthesis of zanamivir phosphonate congeners with potent anti-influenza activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.765861

Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site: design, synthesis, and structural analysis of carbocyclic sialic acid analogues with potent anti-influenza activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.765861

Tamiflu side effects come under scrutiny

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.765861

Oseltamivir resistance--disabling our influenza defenses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.765861

Permissive secondary mutations enable the evolution of influenza oseltamivir resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.765861

New, azide-free transformation of epoxides into 1,2-diamino compounds: synthesis of the anti-influenza neuraminidase inhibitor oseltamivir phosphate (Tamiflu).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.765861

Practical Total Synthesis of the Anti-Influenza Drug GS-4104

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.765861

Efficient access to oseltamivir phosphate (Tamiflu) via the O-trimesylate of shikimic acid ethyl ester.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.765861

Synthesis of tamiflu and its phosphonate congeners possessing potent anti-influenza activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.765861

A concise and flexible synthesis of the potent anti-influenza agents tamiflu and tamiphosphor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.765861

Peramivir for the treatment of influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.765861

Stereoselective total synthesis of racemic BCX-1812 (RWJ-270201) for the development of neuraminidase inhibitors as anti-influenza agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.765861

Structure-based inhibitors of influenza virus sialidase. A benzoic acid lead with novel interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.765861

Recent advances in neuraminidase inhibitor development as anti-influenza drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.765861

The Quenching Effect of Flavonoids on 4-Methylumbelliferone, a Potential Pitfall in Fluorimetric Neuraminidase Inhibition Assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.765861

A screening assay for neuraminidase inhibitors using neuraminidases N1 and N3 from a baculovirus expression system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.765861

Design, synthesis and biological activity of thiazolidine-4-carboxylic acid derivatives as novel influenza neuraminidase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.765861

10.1517/13543776.2013.765861

21 January 2018

Identifiers

DOI

1 reference

21 June 2017

1 reference